Cresco Labs

Cultivates, processes, and sells cannabis products

Chicago, Illinois, United States

About Cresco Labs

Cresco Labs is involved in the U.S. cannabis industry as a grower, processor, and retailer of cannabis products for both recreational and medical users. The company offers a range of trusted brands to meet diverse consumer needs and operates in eleven states with a focus on high-demand markets and strict regulations. Cresco Labs stands out by emphasizing responsible practices, community empowerment, and eco-friendly initiatives, aiming to create a reputable cannabis industry. Its goal is to ensure that its success benefits local communities and stakeholders while delivering high-quality cannabis products.

Chicago, IllinoisHeadquarters

2013Year Founded

$105.1MTotal Funding

IPOCompany Stage

Social Impact, Consumer GoodsIndustries

1,001-5,000Employees

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Unlimited Paid Time Off

Paid Vacation

Paid Holidays

401(k) Company Match

401(k) Retirement Plan

Performance Bonus

Stock Options

Employee Discounts

Risks

Increased competition in Ohio following the legalization of recreational cannabis.

Potential supply chain disruptions due to rapid expansion in Pennsylvania.

Regulatory challenges in maintaining compliance across multiple states.

Differentiation

Cresco Labs operates in eleven states, focusing on high-demand, regulated markets.

The company uses a consumer-packaged-goods approach to cannabis production and distribution.

Cresco Labs emphasizes eco-friendly practices and community empowerment initiatives.

Upsides

Cresco Labs reported a tenfold increase in operating cash flow in Q1 2024.

The company is expanding retail operations, with 72 locations nationally, including Ohio and Pennsylvania.

Cresco Labs' diverse brand portfolio caters to both recreational and medical cannabis users.

Funding

Total raised$105.05 M

Latest valuation$500.00 M

StageIPO

POST IPO DEBT

7/31/2021

$400

POST IPO EQUITY

10/31/2019

$38

SERIES D

9/30/2018

$100

$500.00 M

GROWTH EQUITY VC